Cardiff Met develops new cancer treatment
Cardiff Metropolitan University has been instrumental in the development of a new anti-cancer agent that has the potential to offer a valuable treatment option for cancer...
List view / Grid view
News
Promacta receives Breakthrough Therapy designation for SAA
The FDA has granted Breakthrough Therapy designation to Promacta for use in combination with standard immunosuppressive therapy for severe aplastic anaemia...
Sperm-sorting device may improve IVF success
Women undergoing IVF may become pregnant with fewer treatment cycles thanks to a device that uses an obstacle course to select the fastest and healthiest sperm...
5-FU cream found to reduce the risk of squamous cell carcinoma
Clinical trial results provide evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of SCC...
Removable implant may control type 1 diabetes
Researchers have devised a method for implanting islet cells into a patient that may control the management of type 1 diabetes...
Kisqali receives breakthrough therapy designation for advanced breast cancer
Kisqali receives breakthrough therapy designation for initial endocrine-based treatment of pre- or perimenopausal women with HR+/HER2- advanced or metastatic breast cancer...
Precision NanoSystems named as one of British Columbia’s fastest growing companies
Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published Top 100 fastest-growing companies in BC list from business news journal Business in Vancouver (BIV)...
Silver nanoparticles improve molecular detection in Raman spectroscopy
Researchers have improved molecular detection at low concentration levels by arranging nanoparticles on nanowires to enhance Raman spectroscopy....
Diabetes drug significantly reverses memory loss in Alzheimer’s disease
A drug developed for diabetes could be used to treat Alzheimer's after scientists discover it significantly reversed memory loss in mice through a triple method of action...
Seasonal images reflect stem cells science
University of Southampton postgraduate researcher Catarina Moura creates seasonal images from stem cells as part of her investigation into new optical techniques to monitor the cells' development.
NICE recommends routine access to beta interferon drug for MS
Multiple sclerosis patients to have routine access to beta interferon drug, says NICE in new draft guidance.
Clinical trial transparency reaches record level
Disclosure rate of industry-sponsored clinical trials at 12 months has significantly improved year on year from 71% in 2009 to 93% in 2014, according to ABPI-sponsored study.
Heroin vaccine could tackle opioid addiction
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
FDA approves Nucala for Eosinophilic Granulomatosis with Polyangiitis
The FDA has expanded the approved use of Nucala to treat a rare autoimmune disease that causes vasculitis, an inflammation of the wall of blood vessels of the body...
Joint policy document shows the potential impact of Brexit
The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union...
